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Introduction
Blood platelets fulfill a dual role in the hemostatic process. Their adhesive and aggregating properties affirm the formation of a physical barrier required for the primary arrest of a bleeding. In addition, platelets provide a catalytic surface for the assembly of enzyme complexes of the coagulation cascade to ensure an accelerated fibrin formation. The latter function is referred to as the platelet procoagulant response, which involves a remodeling of the platelet plasma membrane. 1 In quiescent platelets, phosphatidylserine (PS) is maintained in the inner leaflet of the plasma membrane mainly through the action of an aminophospholipid translocase. 2, 3 Stimulation of platelets causes aminophospholipid translocase activity to shut down, while simultaneously switching on the activity of a phospholipid scramblase. These events lead within minutes to a collapse of the normal asymmetric lipid distribution, resulting in surface exposure of negatively charged PS required for the binding of coagulation factor complexes. Despite several studies revealing various properties of the scramblase mechanism, the identity of the membrane protein(s) involved remains unresolved.
2,4,5
A prerequisite for PS exposure in platelets appears to be a persistent elevation of [Ca 2+ ] i , a condition that is particularly accomplished using a combination of the physiological agonists collagen and thrombin. 6 
Material and methods

Reagents
Calcium ionophore ionomycin, bovine serum albumin (BSA, essentially fatty acid free), clotrimazol, quinine hydrochloride, charybdotoxin, apamin, iberiotoxin, and valinomycin were obtained from Sigma (St Louis, MO). Human thrombin was purified as previously described 9 and collagen was from Horm (Nycomed, Münich, Germany). Tirofiban was obtained from MSD (Haarlem, the Netherlands). The coagulation proteins prothrombin, factor Xa and factor Va were purified from bovine blood as described before. 9 Thrombinspecific chromogenic substrate S2238 was obtained from Chromogenix (Mölndal, Sweden).
Fluorescein isothiocyanate (FITC)-conjugated annexin A5 and Fura-2 were from Invitrogen (Leiden, the Netherlands). ATP Bioluminescence Assay Kit HS II was from Boehringer Mannheim (Germany).
Platelet isolation and activation
Platelet isolation was performed as described. 10 Briefly, 10 mL blood was collected in 2 mL anticoagulant ACD (80 mmol/L trisodium citrate, 52 mmol/L citric acid and 180 mmol/L glucose). Platelet rich plasma was obtained by centrifuging whole blood for 15 min at 200 g. Platelets were spun down at 11,500 x g for 2 min using a microfuge. The platelet pellet was resuspended and washed twice with 10 mmol/L HEPES, 137 mmol/L NaCl, 2.7 mmol/L KCl, 2 mmol/L MgCl 2 , 5 mmol/L glucose and 0.5 mg/mL BSA, adjusted at pH 6.6); before each centrifugation step, 100 µL ACD was added to each mL resuspended platelets. Finally, platelets were resuspended in HEPES buffer at pH 7.4. Platelet count was adjusted at 2x10 For experiments with platelets from a patient with Scott syndrome, freshly obtained citrated blood from the patient and a control was shipped by airmail and platelets were isolated and used for experiments immediately upon arrival (approx 24 hours after blood donation).
Platelet prothrombinase activity
Platelet procoagulant activity was assayed as described in more detail elsewhere. 9 Briefly, after activation of 10 7 platelets/mL with collagen (10 µg/mL) and thrombin (4 nmol/L) for 10 min, samples were taken and diluted to 10 6 platelets/mL in HEPES buffer containing 3 mmol/L CaCl 2 and 0.5 mg/mL BSA. The samples were incubated with 0.2 nmol/L factor Xa and 2 nmol/L factor Va for 1 min at 37˚C. Thrombin formation was initiated by addition of 1
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Separation of microparticles from remnant platelets after activation
Platelet activation has been demonstrated to be accompanied by shedding of microparticles from the plasma membrane. 11, 12 To evaluate the contribution of microparticles, we have used a previously described method to separate microparticles from remnant cells. 13 Briefly, after activation, platelet suspensions were centrifuged at 11,500 g; both the prothrombinase activity remaining in the supernatant and the lipid content of the supernatant approached constant values after 3 min centrifugation. This prothrombinase activity is operationally defined as derived from microparticles. The absence of platelets or remnant cells in the supernatant was confirmed by flow cytometry.
Flow cytometry
Samples for flow cytometry were taken simultaneously with samples for the prothrombinase 14 Experiments were performed in triplicate at 37 o C.
Measurement of platelet aggregation and release.
Aggregation was measured at 37°C in 450 µL samples of a platelet suspension of 2x10 8 /mL using an automated model 400 Chronolog aggregometer (Chronolog Corporation, Chicago, USA). After stirring for 2 min at 300 rpm, CaCl 2 (3 mmol/L) was added, 1 min later followed by simultaneous addition of 10 ug/mL collagen and 4 nmol/L thrombin. The resulting aggregation was recorded for 5 min after which 50 µL ATP-reagent (Boehringer Mannheim ATP Bioluminescence Assay Kit HS II) was added to quantify the release reaction.
Statistics
Data are expressed as mean values ± 1 SD. To determine the statistical significance of differences, P-values were calculated by Student's t-test (* P<0.05; ** P<0.01; *** P<0.001) Since microvesicle formation and PS exposure are closely associated events in the procoagulant response [11] [12] [13] , we also studied the effect of a high [K + ] on microvesicle formation in collagen and thrombin activated platelets. Because of their small size, flow cytometry is not particularly suitable for quantifying platelet microparticles. Therefore, formation of microvesicles was operationally defined as residual procoagulant activity in the supernatant of a platelet suspension that was centrifuged at 11,500 x g for 3 min as was described previously. 13, 17 In HEPES/KCl, a 50% reduction in prothrombinase activity of both the supernatant and the total platelet incubation was found, indicating that a reduced PS exposure was accompanied by a reduced formation of microvesicles.
Results
The influence of high extracellular [K + ] on the generation of procoagulant activity
Gardos channel blockers inhibit platelet procoagulant response.
We have tested various K + channel inhibitors for their ability to affect the collagen plus thrombin-induced platelet prothrombinase activity. The results are depicted in Fig. 2A . The , appeared to be the most potent inhibitor, being able to decrease the collagen plus thrombin-induced procoagulant activity by
60±10% (n=6). Two other K
+ channel inhibitors, iberiotoxin and apamin were without effect.
Very similar findings with these inhibitors were obtained when the procoagulant response was measured as the binding of annexin A5 (Fig. 2B) . We could not demonstrate inhibition of clotrimazol, charybdotoxin or quinine on the procoagulant response induced by Ca 2+ -ionophore, ionomycin (5 µmol/L).
To investigate whether inhibition of the procoagulant response by clotrimazol, charybdotoxin and quinine was caused by a preferential effect of these inhibitors on the process of microvesicle formation, we compared the prothrombinase activity of a total suspension of activated platelets with that of its corresponding 11,500 x g supernatant. For each inhibitor, the decrease in prothrombinase activity of the supernatant was similar to that of the total platelet suspension, i.e. the prothrombinase activity of the supernatant varied between 30-35% of that of the total suspension, irrespective the presence of an inhibitor.
Gardos channel blockers decrease the fraction of PS-exposing platelets after collagen plus thrombin stimulation
It has been demonstrated that the procoagulant activity of platelets in suspension is caused by a fraction of the platelets showing maximal PS exposure. Besides a role in supporting blood coagulation, surface exposed PS is a hallmark of the apoptotic process, serving as 'eat me' signal for phagocyting cells. As shown previously, 
No effect of Gardos channel inhibitors on collagen plus thrombin induced aggregation and release.
To investigate whether or not other platelet functions were affected by the presence of K + channel inhibitors under these conditions of platelet stimulation, we studied their effect on aggregation and release of ATP. Neither high extracellular [K + ], nor the presence of clotrimazol or charybdotoxin showed an appreciable effect on aggregation or release ( Table   1 ). (The diminished ATP release observed for platelets in HEPES/KCl appeared to be an apparent decrease, caused by a reduced activity of the ATP reagent (luciferine/luciferase) in this buffer). Quinine caused approx 60% inhibition of the aggregation, but had only a minor effect on the release. It should be noted in this respect, that quinine has also been observed to inhibit phospholipase A 2 , which may result in a decreased thromboxane A 2 production, a secondary stimulator of platelet aggregation. 25 Since we were exclusively interested in inhibitory effects under conditions of platelet stimulation that evoke a procoagulant response, we did not perform dose-response curves for each activator separately. Hence, it cannot be excluded that these K + channel blockers may affect the aggregation and/or release induced by collagen or thrombin at lower dose.
Inhibition of the procoagulant response by Gardos channel blockers is reversed by valinomycin
To verify that the inhibition by clotrimazol, charybdotoxin and quinine was caused by blocking the efflux of K + ions from the cell, valinomycin was used, which acts as a cage carrier selective for K + ions. As shown in Fig. 2A 
Effect of Gardos channel blockers on [Ca 2+ ] i
It is increasingly appreciated that the procoagulant response depends on a persistent elevation ] i with this inhibitor.
The impaired procoagulant response of platelets from a patient with Scott syndrome can be partially corrected by valinomycin.
Platelets from patients with Scott syndrome elicit a partially impaired procoagulant response when activated with collagen plus thrombin and appear to be completely defective in their response to Ca 2+ -ionophore. Here, we used platelets from a Welsh Scott patient, whose clinical features have been described earlier. 26 Indeed, as shown in 
Discussion
Activation of blood platelets, particularly by the combined action of collagen and thrombin, evokes a procoagulant response, which has been attributed to surface exposure of PS in a distinct platelet population, 17 thus producing a catalytic membrane surface that promotes assembly and activity of the prothrombinase and tenase complex of the blood coagulation proteins. 9 In this study we wanted to investigate whether selective inhibition of K + channels present in the plasma membrane could affect the procoagulant response of platelets. A number of studies have demonstrated the presence of both voltage operated K + channels and Ca 2+ -induced K + channels in the plasma membrane of platelets. [27] [28] [29] [30] The latter can be subdivided in three different types, SK (small conductance-), IK (intermediate conductance-) and BK (large conductance-) channels. [31] [32] [33] Whether or not all three types are present in platelets is presently unknown. Of the Ca 2+ -activated K + channels, the IK channel is identical to the Gardos channel, first described in erythrocytes. 34 Distinction between different types of K + channels can be made based on their sensitivity to specific inhibitors. 18, 32, 33 The antifungal agent clotrimazol and charybdotoxin, a high affinity peptide isolated from scorpion venom, specifically block the Gardos channel, although charybdotoxin can also inhibit the large-conductance Ca 2+ -activated K + channel. Iberiotoxin, a peptide also purified from scorpion venom and apamin, isolated from bee venom are blockers of BK and SK channels, respectively. 18, 32, 33 The present study shows that PS exposure, microvesiculation, and prothrombinase activity of platelets stimulated with collagen plus thrombin are markedly attenuated in the presence of specific inhibitors of the Gardos K + channel, charybdotoxin, clotrimazol, and quinine, as well as in the presence of high extracellular K + . This inhibition does not occur with inhibitors of the non-Gardos K + channels (e.g. apamin and iberiotoxin), strongly suggesting that functional Gardos channels are a requisite for the process of PS externalization. Mahaut-Smith et al. 30 have suggested that Ca 2+ -activated K + channels are important in maintaining the membrane potential during stimulated cation influx. Inhibition of these channels would be expected to cause a higher degree of membrane depolarization following platelet activation and consequently reduce the driving force for Ca 2+ entry.
Indeed It is worth recalling that Scott platelets have been shown to expose PS upon treatment with local anesthetics (e.g. tetracain, propranolol) which produce mitochondria-related apoptotic events. 24 These local anesthetics also produce apoptosis and concurrent PS exposure in normal platelets, but this response cannot be inhibited by the Gardos-channel blockers charybdotoxin and clotrimazol. This confirms that PS exposure during apoptosis differs from that during cell activation, as has been shown earlier. 
